137725-22-5

Upstream product

• 137725-18-9 (8R,9S,13S,14R,17S)-14,17-Bis-hydroxymethyl-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ol 
• 104512-90-5 14,17α-Diformyl-3-methoxy-14α-estra-1,3,5(10)-trien-17β-yl acetate 
• 100-39-0 benzyl bromide 
• 137725-21-4 (17S)-2',2'-dimethylspiro<14-hydroxymethyl-3-methoxyestra-1,3,5(10)-triene-17,4'<1,3>dioxolane> 

Downstream Products

• 137725-23-6 14-benzyloxymethyl-17α-hydroxymethyl-3-methoxyestra-1,3,5(10)-triene-17-β-ol 
• 137725-37-2 Toluene-4-sulfonic acid (8R,9S,13S,14R,17S)-14-benzyloxymethyl-17-hydroxy-3-methoxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ylmethyl ester 
• 137725-39-4 14-benzyloxymethyl-3-methoxyestra-1,3,5(10)-triene-17ζ-carbaldehyde 
• 137725-38-3 14-benzyloxymethyl-3-methoxy-17-methylgona-1,3,5⁽¹⁰⁾,13⁽¹⁷⁾-tetraene 

Relevant academic research and scientific papers

Chemoselective reactioms of 14,17α-bis(hydroxymethyl)-3-methoxyestra-1,3,5(10)-trien-17β-ol. Synthesis of novel 14,17-hetero-bridged 19-norsteroids

Chemoselective differentiation of the primary hydroxy groups in 14,17α-bis(hydroxymethyl)-3-methoxyestra-1,3,5(10)-trien-17β-ol (2) has been investigated in a series of reactions which lead inter alia to novel 14,17-hetero-bridged steroid hormone analogue